+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Brachytherapy Seeds Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 163 Pages
  • December 2023
  • Region: Global
  • Expert Market Research
  • ID: 5921595
According to the report, the global brachytherapy seeds market is projected to grow at a CAGR of 8.5% between 2024 and 2032. Aided by the rising incidence of cancer globally and the increasing acceptance of targeted radiation therapies, the market is expected to grow significantly by 2032.

Brachytherapy, often termed internal radiation therapy, involves the placement of radioactive seeds or sources directly into or near the tumour. These seeds emit radiation, eradicating the cancer cells while ensuring minimal damage to the adjacent healthy tissue. The efficacy, precision, and minimised side effects of this treatment have positioned brachytherapy as a favoured therapeutic approach for various cancers, including prostate, cervical, and breast cancer.

The disconcerting rise in cancer cases worldwide serves as the primary driver for the brachytherapy seeds market growth. As the global populace grapples with this formidable disease, the demand for effective and efficient treatments has surged. Brachytherapy, with its targeted approach and reduced treatment duration, offers an optimal solution, leading to its increasing adoption.

Further bolstering the market is the growing awareness of brachytherapy and its benefits. Healthcare professionals, recognising the potential of brachytherapy seeds in ensuring better patient outcomes, are increasingly recommending this treatment modality, especially for early-stage cancers.

As per the brachytherapy seeds market analysis, technological advancements have enriched the realm of brachytherapy. Modern seeds, characterised by enhanced biocompatibility, optimal radiation dose, and improved half-life, ensure better therapeutic outcomes. The integration of advanced imaging techniques, like MRI and CT, with brachytherapy has also elevated its precision, further enhancing its appeal.

However, while the merits of brachytherapy are manifold, it faces competition from alternative radiation therapies, including external beam radiation. Additionally, the initial cost associated with brachytherapy, although offset by reduced treatment sessions, can sometimes act as a deterrent for its adoption.

Nevertheless, with increasing investments in research and development, the introduction of cost-effective brachytherapy seeds, and the global thrust towards personalised cancer treatments, the market promises robust growth. The collaborations between medical device manufacturers, hospitals, and research institutions are further expected to influence the brachytherapy seeds market outlook, introducing innovative products and techniques.

Market Segmentation

The market can be divided based on technique and region.

Market Breakup by Technique

  • High-Dose Rate (HDR) Brachytherapy
  • Low-Dose Rate (LDR) Brachytherapy

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Competitive Landscape

The report looks into the market shares, plant turnarounds, capacities, investments, and mergers and acquisitions, among other major developments, of the leading companies operating in the global brachytherapy seeds market. Some of the major players explored in the report are as follows:
  • Becton, Dickinson and Company
  • Eckert and Ziegler BEBIG
  • IsoAid LLC
  • Isoray Inc.
  • Theragenics Corporation
  • Others

Table of Contents

1 Preface2 Report Coverage - Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Brachytherapy Seeds Market Analysis
8.1 Key Industry Highlights
8.2 Global Brachytherapy Seeds Historical Market (2018-2023)
8.3 Global Brachytherapy Seeds Market Forecast (2024-2032)
8.4 Global Brachytherapy Seeds Market by Technique
8.4.1 High-Dose Rate (HDR) Brachytherapy
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.2 Low-Dose Rate (LDR) Brachytherapy
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.5 Global Brachytherapy Seeds Market by Region
8.5.1 North America
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Europe
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.3 Asia Pacific
8.5.3.1 Historical Trend (2018-2023)
8.5.3.2 Forecast Trend (2024-2032)
8.5.4 Latin America
8.5.4.1 Historical Trend (2018-2023)
8.5.4.2 Forecast Trend (2024-2032)
8.5.5 Middle East and Africa
8.5.5.1 Historical Trend (2018-2023)
8.5.5.2 Forecast Trend (2024-2032)
9 North America Brachytherapy Seeds Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe Brachytherapy Seeds Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2018-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2018-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2018-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Brachytherapy Seeds Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2018-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2018-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2018-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.2 Historical Trend (2018-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Brachytherapy Seeds Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2018-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2018-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Brachytherapy Seeds Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2018-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2018-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter's Five Forces Analysis
14.2.1 Supplier's Power
14.2.2 Buyer's Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 Becton, Dickinson and Company
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 Eckert and Ziegler BEBIG
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 IsoAid LLC
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 Isoray Inc.
16.2.4.1 Company Overview
16.2.4.2 Product Portfolio
16.2.4.3 Demographic Reach and Achievements
16.2.4.4 Certifications
16.2.5 Theragenics Corporation
16.2.5.1 Company Overview
16.2.5.2 Product Portfolio
16.2.5.3 Demographic Reach and Achievements
16.2.5.4 Certifications
16.2.6 Others
17 Key Trends and Developments in the Market

Companies Mentioned

  • Becton Dickinson and Co. [BDX (NYSE)]
  • Eckert & Ziegler AG [EUZ (ETR)]
  • IsoAid LLC
  • Isoray Inc. [ISR (NYSEAMERICAN)]
  • Theragenics Corp.

Methodology

Loading
LOADING...